fda compounding glp-1 enforcement news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Why the FDA Issued 30

Until formal studies confirm long-term outcomes, it remains an exciting but exploratory option in the world of skin boosters

Herbal teas offer a caffeine-free alternative that many patients tolerate well

Biological Activities and Potential Oral Applications of N-Acetylcysteine: Progress and Prospects

Using more diluent makes the solution less concentrated (fewer mcg per unit), which can make measuring smaller doses easier

Ph n ang mang thai, cho con b, ngi ang iu tr bnh nn tham kho kin chuyn gia trc khi s dng

Disord Fluid Electrolyte Metabol 52:8092 Acknowledgements The authors gratefully acknowledge the patients whose cases are presented in this publication for their gracious consent